Sign in

CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980443284
Phone
858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-29 Shapiro Aron Director Grant or award · Stock Option (right to buy) +5,000 5,000
2023-09-29 Stengone Carmine N. Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-09-29 Hollander David Director Grant or award · Stock Option (right to buy) +0 5,000
2023-09-29 Gayron Kenneth L Director Grant or award · Stock Option (right to buy) +5,000 5,000
2023-09-29 Parsons Erin Director Grant or award · Stock Option (right to buy) +5,000 5,000
2023-03-03 Parsons Erin Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-03-03 Tosca Melissa EVP Finance Grant or award +2,400 7,400
2023-03-03 Tosca Melissa EVP Finance Grant or award · Stock Option (right to buy) +1,600 1,600
2023-03-03 Strem Brian M. President and CEO Grant or award +15,600 $3.83 $60K 28,783
2023-03-03 Strem Brian M. President and CEO Grant or award · Stock Option (right to buy) +10,400 10,400
2023-03-03 Daniels Eric Joseph Chief Development Officer Grant or award +15,600 25,838
2023-03-03 Daniels Eric Joseph Chief Development Officer Grant or award · Stock Option (right to buy) +10,400 10,400
2023-03-03 Gayron Kenneth L Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-03-03 Shapiro Aron Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-03-03 TYLE PRAVEEN Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-03-03 Hollander David Director Grant or award · Stock Option (right to buy) +8,000 8,000
2023-03-03 CHANEY PAUL G Director Grant or award · Stock Option (right to buy) +8,000 8,000
2022-10-21 Daniels Eric Joseph Chief Development Officer Grant or award +10,000 10,238
2022-10-21 Daniels Eric Joseph Chief Development Officer Grant or award · Stock Option (right to buy) +15,000 15,000
2022-10-21 Tosca Melissa EVP of Finance Grant or award +2,500 2,500

Page 4 of 7 · 130 trades